REN and hypertensive disorder: ROS modulate several pathways in HTN leading to decreased bioavailability of NO, increased inflammation, hyperactivity of the sympathetic nervous system, and disturbance of the renin–angiotensin–aldosterone system (RAAS) [29, 30].